OCP/DARS new clinical studies IDIQ 5 year contract with M ceiling

Forecast Overview

NAICS

541714

Performance end

1/2026

OCP/DARS new clinical studies IDIQ 5 year contract to support new clinical studies 5 year IDIQ w/50mil ceiling.

Source

Source

HHS SBCX Forecast Export

Source file

Forecast.csv

Official source

Agency forecast source

Last verified

2026-08-31

Agency-published contact: · TBD@fda.hhs.gov

Related Federal Entities

• Department of Health and Human Services · agency
• OCP/DARS IDIQ 5 year purchase of cells · related forecast
• PK IDIQ- Post-market Bioequivalence of Generic Drug Products · related forecast
• OMUFA - Screening Non-Sterile OTC Monograph Products for Microbial Contamination · related forecast
• Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (ChemDB) · related forecast
• Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases · related forecast
• Federal Technology Spending Map · spending map
• Federal Opportunity Research · resource